HPLC Purity of Research Peptides: How the Percentage Is Determined

HPLC purity of a synthetic peptide is the percentage of the total peak area on a reversed-phase HPLC chromatogram that belongs to the main peak, recorded under stated column, mobile-phase, gradient and detection-wavelength conditions. It is an area-percent value: it describes the composition of the peptide-related material integrated on the chromatogram and says nothing about counter-ion, water or the mass of solid in a vial. The reported purity on a Pepta Labs product page is this area-percent figure from an independent laboratory's report on a sampled production run.

What does reversed-phase HPLC separate, and what does a peptide chromatogram show?

Reversed-phase HPLC (RP-HPLC) separates the components of a dissolved peptide sample by hydrophobicity. A pump drives the sample through a column packed with a non-polar stationary phase, most often C18-bonded silica, using a polar mobile phase of water (mobile phase A) and acetonitrile (mobile phase B), each containing about 0.1% trifluoroacetic acid or formic acid. Components that interact more strongly with the C18 chains leave the column later, so peptides elute broadly in order of increasing hydrophobicity.

The acid in the mobile phase pairs with the protonated amino groups of the peptide, which sharpens the peaks and makes retention reproducible. A UV detector at the column outlet records absorbance against time; that trace is the chromatogram, and each separated component appears as a peak. Closely related sequences, such as a chain missing one residue or carrying one oxidized residue, usually differ enough in hydrophobicity to form a separate peak, which is why RP-HPLC is the standard purity method for synthetic peptides. The site glossary gives the short definition under RP-HPLC.

What is a gradient, and why does the report state it?

A gradient is the programmed change in mobile-phase composition during a run: the acetonitrile fraction (mobile phase B) rises from a starting percentage to an end percentage over a stated number of minutes. A common peptide method runs from about 5% to 60% B over 20 to 30 minutes at 1.0 mL/min on a 4.6 mm internal-diameter column; a shallower gradient spreads closely eluting peaks further apart.

Retention time depends on the gradient, the flow rate, the column dimensions and chemistry, the column temperature and the instrument's dwell volume. A retention time is therefore comparable only between runs made under the same conditions. A main peak at 14.2 minutes on one laboratory's report and 17.8 minutes on another's is not a discrepancy unless both reports state the same column, gradient, flow and temperature.

At which wavelength are peptides detected?

Peptide purity is usually measured at 214 or 220 nm, where the amide (peptide) bond absorbs. Absorbance at these wavelengths comes mainly from the peptide bonds along the backbone, so the detector response per unit mass is broadly similar for the target and its closely related impurities, which is what makes an area-percent figure meaningful. A wavelength of 280 nm reads only aromatic side chains, chiefly tryptophan and tyrosine, and is sometimes reported alongside 214 or 220 nm for sequences that contain them.

How is the HPLC purity percentage calculated?

HPLC purity is the main-peak area divided by the sum of all integrated peak areas, multiplied by 100. The calculation runs in four steps:

1. The chromatography data system detects every peak above the reporting threshold stated in the method and draws a baseline under each one.
2. It integrates each peak: the area between the trace and the baseline, in units such as mAU·s.
3. It sums the areas of all integrated peaks. Peaks that also appear in a blank run (the solvent front, system peaks, and the counter-ion near the void volume) are excluded when the method says so.
4. It divides the main-peak area by the total integrated area and multiplies by 100.

Worked example with illustrative numbers (not a Pepta Labs record): a trace with a main peak of 9,920 mAU·s and three minor peaks of 38, 25 and 17 mAU·s has a total integrated area of 10,000 mAU·s, so its purity is 9,920 / 10,000 × 100 = 99.2%.

The integration parameters (detection threshold, peak-width setting, baseline type, and whether a shoulder is split from the main peak or merged into it) change the areas, so they belong on the report. Two laboratories integrating the same trace can arrive at values that differ in the first decimal place, and a shoulder merged into the main peak raises the stated purity.

What are the typical peptide-related impurities in a chromatogram?

The minor peaks on a synthetic-peptide chromatogram are mostly by-products of solid-phase synthesis and of later chemical change in specific residues. Each has a characteristic mass difference from the target, computed below from the residue formula; the mass spectrometry identity guide sets out how an observed mass difference is read against the calculated mass.

• Deletion sequences: one residue missing because a coupling step was incomplete. The mass is lower by that residue's mass, for example −57.02 Da for glycine, −97.05 Da for proline or −128.09 Da for lysine.
• Truncated sequences: chains that stopped growing before the last coupling. When the synthesis caps unreacted chains with acetic anhydride, the shorter chain carries an acetyl group (+42.01 Da on the truncated sequence).
• Oxidized methionine: methionine sulfoxide, +15.99 Da. The sulfoxide is more polar than the thioether, so it usually elutes just before the main peak.
• Deamidated asparagine or glutamine: conversion of the side-chain amide to a carboxylic acid, +0.98 Da. That shift sits under the natural carbon-13 isotope peak of the target, so chromatography, not a low-resolution mass spectrum, is what separates it.
• Residual protecting groups: side-chain groups not removed at the final cleavage, such as tert-butyl (+56.06 Da), Boc (+100.05 Da), trityl (+242.11 Da) or Pbf (+252.08 Da). They add hydrophobicity, so these species elute after the main peak.
• Diastereomers: a residue whose configuration inverted during coupling. A diastereomer has exactly the same mass as the target (0 Da difference), so only chromatography can separate it.

An HPLC-UV report lists the retention time and area of each minor peak; it does not identify what each minor peak is. Assigning a minor peak to one of these species requires LC-MS of that peak, which is a separate analysis.

Which listed peptides contain tryptophan, tyrosine, methionine, asparagine or glutamine?

A sequence decides which of the impurities above can form and whether a 280 nm trace means anything. From the sequences on the Pepta Labs compound records:

• BPC-157 (GEPPPGKPADDAGLV, 15 residues) contains no tryptophan, tyrosine, methionine, asparagine or glutamine, so it is read at 214 or 220 nm, and no methionine-sulfoxide or deamidation species can form from its sequence.
• TB-500 (43 residues, N-terminally acetylated) contains one methionine, one asparagine and three glutamine residues and no tryptophan or tyrosine.
• Semax (MEHFPGP, 7 residues) has methionine at the N-terminus.
• Sermorelin (29 residues) contains two tyrosine residues, one methionine, one asparagine and two glutamine residues, so it absorbs at 280 nm as well as at 214 nm.
• Melanotan-II (7 residues, cyclic lactam) contains one tryptophan and one norleucine; norleucine is the sulfur-free isostere of methionine, so that residue cannot form a sulfoxide.
• Ipamorelin (5 residues) contains D-2-naphthylalanine and D-phenylalanine; a diastereomer with an L-residue at either position has the same mass as the target and is separated only by chromatography.

What is the difference between assay and purity in HPLC?

Purity, as reported from HPLC, is the percentage of the total detected peak area that belongs to the main compound; assay, or content, is the absolute amount of the compound present, determined against a reference standard of known content or by amino-acid analysis. An HPLC assay uses the same instrument with a different calculation: the main-peak area of the sample is compared with the main-peak area of a reference standard run under the same conditions, which gives an amount rather than a share.

A 99% pure sample can therefore have a net peptide content far below 99%. Counter-ions (trifluoroacetate, 113.02 g/mol per anion, or acetate, 59.04 g/mol per anion) and residual water are part of the solid's mass, but they produce no integrated peptide peak. The TFA vs acetate guide covers the counter-ion arithmetic, and how net peptide content is determined covers the separate methods. The figures on Pepta Labs listings are HPLC purity values, not assay values, and net peptide content is not part of the HPLC and mass-spectrometry reporting for Pepta Labs listings.

What does USP <621> define for a chromatographic method?

USP General Chapter <621> Chromatography defines the parameters that describe a chromatographic procedure and the system-suitability tests that are run before sample results are accepted. A purity report written in the chapter's terms states the column (stationary phase, length, internal diameter, particle size), the mobile phases, the gradient, the flow rate, the column temperature, the detection wavelength and the sample volume loaded. System suitability is reported as the tailing factor of the main peak (its symmetry), the resolution between the main peak and its nearest neighbour, the relative standard deviation of replicate runs, and the plate count of the column. The numeric acceptance limits are set by the method and the chapter and are not reproduced here.

What each HPLC report line means

What does "HPLC tested" mean on a peptide listing?

Every Pepta Labs product page has a Purity row that gives the figure as a percentage "by HPLC", to one decimal place, and an Identity row that reads "Confirmed by mass spectrometry". The purity number is the laboratory's area-percent figure for a sampled production run. Pepta Labs describes the testing behind it in these words: "Independent third-party HPLC purity analysis and mass-spectrometry identity confirmation, commissioned through the purchasing group on a sampled production run from the source. Pepta Labs does not test in-house."

The report is "Sent by email on request, before you order if you want to see it first." It covers the sampled production run, not an individual vial: "Vial labels identify the compound, quantity and research-use designation. They do not carry lot or batch numbers." The quality page sets out how testing is commissioned, and Pepta Labs states the limit of that scope directly: "Sterility, endotoxin or LAL, potency, pharmaceutical-grade, cGMP, contaminant-panel and vial fill-quantity testing are not claimed."

How do you check a peptide purity report?

1. Request the report for the listing (report request).
2. Match the compound name, formula and molecular weight on the report to the listing.
3. Note whether the report includes a chromatogram image and a peak table with retention times and areas, or states the percentage alone; the fields listed for Pepta Labs reports are set out on the quality page.
4. Where the report states them, read the column, gradient, flow, temperature and wavelength lines.
5. Where a peak table is included, recompute the purity: main-peak area divided by the total of the listed areas, times 100, and compare it with the stated figure.
6. Read the mass-spectrometry line for identity; the certificate of analysis guide reads every field of the report in order.

Frequently asked questions

What does 99.2% HPLC purity mean?

It means 99.2% of the total integrated peak area on the reversed-phase chromatogram belongs to the main peak, under the column, gradient and wavelength conditions stated on the report.

Why do two laboratories report different purity for the same material?

Because area-percent depends on the column, gradient, wavelength and integration settings, so figures are comparable only between runs made under the same stated conditions.

Does HPLC purity include the counter-ion and water?

No; trifluoroacetate and acetate elute at or near the void volume and are normally excluded from the integration of peptide-related peaks when the method says so, and water gives no detector response, so none of them is counted in an area-percent purity figure.

What wavelength is used for peptide purity?

Usually 214 or 220 nm, where the peptide bond absorbs, with 280 nm sometimes reported alongside for peptides containing tryptophan or tyrosine.

Is HPLC purity the same as assay?

No; assay is the absolute content of the compound measured against a reference standard, while purity is the relative share of the chromatogram, and the figures on Pepta Labs listings are HPLC purity values.

Does HPLC purity confirm which peptide the sample is?

No; a chromatogram shows how uniform the peptide-related material is, and only mass spectrometry, which compares an observed mass with the mass calculated from the molecular formula, confirms that the main peak is the expected molecule.

Sources

• USP General Chapter <621> Chromatography.
• Pepta Labs glossary entries "RP-HPLC" and "Purity vs assay" (peptide guide); sequences from the Pepta Labs compound records shown on each listing.

All products are supplied for laboratory research use only and are not for human or animal use.